Back-to-school supply strain challenges ADHD drug market

Back-to-school supply strain challenges ADHD drug market


Ten milligram tablets of the hyperactivity ​drug, ⁣Adderall, made ​by Shire ​Plc.

Jb Reed |⁤ Bloomberg | Getty Images

It’s been 10⁢ months since the‌ Food and‌ Drug Administration first announced a nationwide shortage of Adderall — one of the most widely used medications for ​attention⁤ deficit ⁤hyperactivity disorder — and the supply strain could potentially worsen in the months ahead.

While some supply issues ⁣have improved, many‌ Americans are still⁢ struggling to find and fill prescriptions for the drug and other ‍medications ⁣for​ ADHD that they ​often ​rely on‍ to stay‍ focused ⁢and complete daily tasks.

Drug-shortage experts told ‌CNBC that it’s extremely difficult to forecast ‍how much longer ⁤the shortages will last because of‌ the lack of transparency in the pharmaceutical industry — and some are concerned about market conditions as children, who are commonly ‌affected ​by ADHD, head back to school.

“Unfortunately, we might see the​ shortage worsen. We are heading into⁢ back-to-school time, so I am…

2023-08-26 07:00:02
Article from www.cnbc.com

Exit mobile version